Clinical scoring systems in cystic fibrosis

Pediatric Pulmonology

Volumn 41, Issue 7, 2006, Pages 602-617

  Hafen, Gaudenz M ^a   Ranganathan, Sarath C ^a,b   Robertson, Colin F ^a,b   Robinson, Philip J ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cystic fibrosis; Evaluation; NIH score; Pulmonary exacerbation; Reliability; Review; Scoring system; Shwachman; Validity

Indexed keywords

ARTICLE; COOPERMAN BERNEZE SCORE; CYSTIC FIBROSIS; DISEASE EXACERBATION; DISEASE SEVERITY; EVALUATION; FOLLOW UP; HUMAN; LUNG TRANSPLANTATION; NIH SCORE; OUTCOMES RESEARCH; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RELIABILITY; SCORING SYSTEM; SHWACHMAN KULCZYCKI SCORE; VALIDATION PROCESS;

CHILD; CHRONIC DISEASE; CYSTIC FIBROSIS; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 33745763147     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20376     Document Type: Article

References (72)

1. Shwachman H, Kulczycki LL. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child 1958;96:6-15.
2. Santos CI, Ribeiro JD, Ribeiro AF, Hessel G. Critical analysis of scoring systems used in the assessment of cystic fibrosis severity: state of the art. J Bras Pneumol 2004;30:286-298.
3. Chrispin AR, Norman AP. The systematic evaluation of the chest radiograph in cystic fibrosis Pediatr Radiol 1974;2:101-106.
4. Brasfield D, Hicks G, Soong S, Tiller RE. The chest roentgenogram in cystic fibrosis: a new scoring system. Pediatrics 1979;63:24-29.
5. van der Put JM, Meradji M, Danoesastro D, Kerrebijn KF. Chest radiographs in cystic fibrosis. A follow-up study with application of a quantitative system. Pediatr Radiol 1982;12:57-61.
6. Weatherly MR, Palmer CG, Peters ME, Green CG, Fryback D, Langhough R, Farrell PM. Wisconsin cystic fibrosis chest radiograph scoring system. Pediatrics 1993;91:488-495.
7. Conway SP, Pond MN, Bowler I, Smith DL, Simmonds EJ, Joanes DN, Hambleton G, Hiller EJ, Stableforth DE, Weller P. The chest radiograph in cystic fibrosis: a new scoring system compared with the Chrispin-Norman and Brasfield scores. Thorax 1994;49:860-862.
8. Abbott J, Webb K, Dodd M. Quality of life in cystic fibrosis. J R Soc Med [Suppl] 1997;90:37-42.
9. Modi AC, Quittner AL. Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis. J Pediatr Psychol 2003;28:535-545.
10. Doershuk CF, Matthews LW, Tucker AS, Nudleman H, Eddy G, Wise M, Spector S. A 5 year clinical evaluation of a therapeutic program for patients with cystic fibrosis. J Pediatr 1964;65:677-693.
11. Cooperman EM, Park M, McKee J, Assad JP. A simplified cystic fibrosis scoring system (a preliminary report). Can Med Assoc J 1971;105:580-582.
12. Taussig LMKJ, Friedewald WT, di Sant'Agnese PA. A new prognostic score and clinical evaluation system for cystic fibrosis. J Pediatr 1973;82:380-390.
13. Kraemer R, Rudeberg A, Klay M, Rossi E. Relationship between clinical conditions, radiographic findings and pulmonary functions in patients with cystic fibrosis. Helv Paediatr Acta 1979;34:417-428.
14. Huang N, Keith H, Palmer J, Hsuan F. A scoring system for short-term evaluation of patients with cystic fibrosis: a possible means for assessment of antibiotic efficacy. In: Warwick WJ, editor. 1,000 years of cystic fibrosis collected papers. University of Minnesota Department of Pediatrics Medical School in cooperation with International Cystic Fibrosis Association, National Heart, Lung and Blood Institute and Fogarty International Center. Minneapolis: University of Minnesota Press 1981. p 207-215.
15. Matouk E, Ghezzo RH, Gruber J, Hidvegi R, Gray-Donald K. Internal consistency reliability and predictive validity of a modified N. Huang clinical scoring system in adult cystic fibrosis patients. Eur Respir J 1997;10:2004-2013.
16. Kanga J, Kuhn R, Craigmyle L, Haverstock D, Church D. Cystic fibrosis clinical score: a new scoring system to evaluate acute pulmonary exacerbation. Clin Ther 1999;21:1343-1356.
17. Rosenfeld M, Emerson J, Williams-Warren J, Pepe M, Smith A, Montgomery AB, Ramsey B. Defining a pulmonary exacerbation in cystic fibrosis. J Pediatr 2001;139:359-365.
18. Rabin HR, Butler SM, Wohl ME, Geller DE, Colin AA, Schidlow DV, Johnson CA, Konstan MW, Regelmann WE. Pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol 2004;37:400-406.
19. Piepsz A, Wetzburger C, Spehl M, Machin D, Dab I, Ham HR, Vandevivere J, Baran D. Critical evaluation of lung scintigraphy in cystic fibrosis: study of 113 patients. J Nucl Med 1980;21:909-913.
20. Cropp GJ, Pullano TP, Cerny FJ, Nathanson IT. Exercise tolerance and cardiorespiratory adjustments at peak work capacity in cystic fibrosis. Am Rev Respir Dis 1982;126:211-216.
21. Cabrera ME, Lough MD, Doershuk CF, Salvator AE. An expanded scoring system including an index of nutritional status for patients with cystic fibrosis. Pediatr Pulmonol 1994;18:199-205.
22. Nathanson I, Conboy K, Murphy S, Afshani E, Kuhn JP. Ultrafast computerized tomography of the chest in cystic fibrosis: a new scoring system. Pediatr Pulmonol 1991;11:81-86.
23. Bhalla M, Turcios N, Aponte V, Jenkins M, Leitman BS, McCauley DI, Naidich DP. Cystic fibrosis: scoring system with thin-section CT. Radiology 1991;179:783-788.
24. Santamaria F, Grillo G, Guidi G, Rotondo A, Raia V, de Ritis G, Sarnelli P, Caterino M, Greco L. Cystic fibrosis: when should high-resolution computed tomography of the chest be obtained? Pediatrics 1998;101:908-913.
25. Brody AS, Klein JS, Molina PL, Quan J, Bean JA, Wilmott RW. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 2004;145:32-38.
26. Tiddens HA. Detecting early structural lung damage in cystic fibrosis. Pediatr Pulmonol 2002;34:228-231.
27. Conway SP, Littlewood JM. Cystic fibrosis clinical scoring systems. In: Dodge JA, Brock DJ, Widdicombe JH, editors. Cystic fibrosis-current topics. Volume 3. New York: John Wiley & Sons; p 1996. 339-358.
28. Dakin C, Henry RL, Field P, Morton J. Defining an exacerbation of pulmonary disease in cystic fibrosis. Pediatr Pulmonol 2001;31:436-442.
29. Schoeni MH. Presentation and critical comparison of clinical scoring systems in patients with cystic fibrosis. Klin Padiatr 1993;205:3-8.
30. Sockrider MM, Swank PR, Seilheimer DK, Schidlow DV Measuring clinical status in cystic fibrosis: internal validity and reliability of a modified NIH score. Pediatr Pulmonol 1994;17:86-96.
31. Taussig LM. The score is... Pediatr Pulmonol 1994;17:279-280.
32. Ramsey BW, Boat TF. Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference. J Pediatr 1994;124:177-192.
33. Streiner DL, Norman GR. Health measurement scales. A practical guide to their development and use. Oxford: Oxford University Press; 2003, p 1-283.
34. Robinson PGER, Fraser J. Cystic fibrosis in New Zealand: incidence and mortality data. N Z Med J 1976;83:268-270.
35. Lewis PA, Morison S, Dodge JA, Geddes D, Coles EC, Russell G, Littlewood JM, Scott MT. Survival estimates for adults with cystic fibrosis born in the United Kingdom between 1947 and 1967. The UK Cystic Fibrosis Survey Management Committee. Thorax 1999;54:420-422.
36. Australasian Cystic Fibrosis Data Registry Advisory Committee. Australasian CF data registry: cystic fibrosis in Australia and New Zealand 2002. North Ryde: Cystic Fibrosis Australia; 2002.
37. Matouk E, Ghezzo RH, Gruber J, Hidvegi R, Gray-Donald K. Construct and longitudinal validity of a modified Huang clinical scoring system in adult cystic fibrosis patients. Eur Respir J 1999;13:552-559.
38. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992;326:1187-1191.
39. Milla CE, Warwick WJ. Risk of death in cystic fibrosis patients with severely compromised lung function. Chest 1998;113:1230-1234.
40. Robinson W, Waltz DA. FEV(1) as a guide to lung transplant referral in young patients with cystic fibrosis. Pediatr Pulmonol 2000;30:198-202.
41. Liou TG, Adler FR, Cahill BC, FitzSimmons SC, Huang D, Hibbs JR, Marshall BC. Survival effect of lung transplantation among patients with cystic fibrosis. JAMA 2001;286:2683-2689.
42. Liou TG, Adler FR, Fitzsimmons SC, Cahill BC, Hibbs JR, Marshall BC. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001;153:345-352.
43. Mayer-Hamblett N, Rosenfeld M, Emerson J, Goss CH, Aitken ML. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med 2002;166:1550-1555.
44. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002;34:91-100.
45. Liou TG, Cahill BC, Adler FR, Marshall BC. Selection of patients with cystic fibrosis for lung transplantation. Curr Opin Pulm Med 2002;8:535-541.
46. Liou TG, Adler FR, Cahill BC, FitzSimmons SC, Huang D, Hibbs JR, Marshall BC. Priorities for lung transplantation among patients with cystic fibrosis. JAMA 2002;287:1523-1525.
47. Liou TG, Adler FR, Huang D. Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am J Respir Crit Care Med 2005;171:1053-1059.
48. Doershuk CF, Stern RC. Timing of referral for lung transplantation for cystic fibrosis: overemphasis on FEV1 may adversely affect overall survival. Chest 1999;115:782-787.
49. Terheggen-Lagro S, Truijens N, van Poppel N, Gulmans V, van der Laag J, van der Ent C. Correlation of six different cystic fibrosis chest radiograph scoring systems with clinical parameters. Pediatr Pulmonol 2003;35:441-445.
50. Koscik RE, Kosorok MR, Farrell PM, Collins J, Peters ME, Laxova A, Green CG, Zeng L, Rusakow LS, Hardie RC, Campbell PW, Gurney JW, Wisconsin cystic fibrosis chest radiograph scoring system: validation and standardization for application to longitudinal studies. Pediatr Pulmonol 2000;29:457-467.
51. de Jong PAOM, Robben SG, Lequin MH, Hop WC, Hendriks JJ, Pare PD, Tiddens HA. Pulmonary disease assessment in cystic fibrosis: comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology 2004;231:434-439.
52. McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires. New York: Oxford University Press; 1996. 523 p.
53. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
54. Ahmed ML, Ong KK, Thomson AH, Dunger DB. Reduced gains in fat and fat-free mass, and elevated leptin levels in children and adolescents with cystic fibrosis. Acta Paediatr Scand 2004;93:1185-1191.
55. Chemery L, Fekete K, Guillot S, Roussey M, Desrues B, Dabadie A, Belleguic C, Deneuville E, Dassonville J. Diffusing capacity for carbon monoxide (T(LCO)) and oxygen saturation during exercise in patients with cystic fibrosis. Arch Pediatr 2004;11:1060-1066.
56. Merkus PJ, Govaere ES, Hop WH, Stam H, Tiddens HA, de Jongste JC. Preserved diffusion capacity in children with cystic fibrosis. Pediatr Pulmonol 2004;37:56-60.
57. Alvarez AE, Ribeiro AF, Hessel G, Bertuzzo CS, Ribeiro JD. Cystic fibrosis at a Brazilian center of excellence: clinical and laboratory characteristics of 104 patients and their association with genotype and disease severity. J Pediatr (Rio J) 2004;80:371-379.
58. Kumar N, Balachandran S, Millner PA, Littlewood JM, Conway SP, Dickson RA. Scoliosis in cystic fibrosis: is it idiopathic? Spine 2004;29:1990-1995.
59. Lewiston NMR, Hindi R, Rubinstein S, Sullivan M. Interobserver variance in clinical scoring for cystic fibrosis. Chest 1987;91:878-882.
60. Lanotte P, Mereghetti L, Lejeune B, Massicot P, Quentin R. Pseudomonas aeruginosa and cystic fibrosis: correlation between exoenzyme production and patient's clinical state. Pediatr Pulmonol 2003;36:405-412.
61. Legris GJ, Dearborn D, Stern RC, Geiss CL, Hopfer U, Douglas JG, Doershuk CF. Sodium space and intravascular volume: dietary sodium effects in cystic fibrosis and healthy adolescent subjects. Pediatrics 1998;101:48-56.
62. Wielinski CLWW, Budd JR. Mortality and progression of the NIH clinical and prognostic score. Pediatric Pulmonology [Suppl] 1990;16:259-260.
63. Scherrer M, Zeller C, Bachofen H. Arterial CO2- and O2-partial pressure at rest and during exertion in pulmonary emphysema [in German]. Schweiz Med Wochenschr 1977;107:1072-1076.
64. Huang NNL-CL, Yasmin N, Keith HH. Efficacy of sisomicin in patients with cystic fibrosis. Infection 1976;4:465.
65. McIlwaine PM, Wong LT, Peacock D, Davidson AG. Long-term comparative trial of positive expiratory pressure versus oscillating positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis. J Pediatr 2001;138:845-850.
66. Economou A, Karagianni P, Melidis D, Papadopoulou F, Tsanakas I, Manavis I, Efremidis S. Lung HRCT in cystic fibrosis: correlation with clinical and chest-X-ray subscore. In: Abstract Book European Congress of Radiology 2000. Vienna, European Congress of Radiology; 2000, Presentation 602.
67. Ramsey BW, Pepe MS, Quan JM, Otto KL, Montgomery AB, Williams-Warren J, Vasiljev KM, Borowitz D, Bowman CM, Marshall BC, Marshall S, Smith AL. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 1999;340:23-30.
68. Morgan WJ, Butler SM, Johnson CA, Colin AA, FitzSimmons SC, Geller DE, Konstan MW, Lighl MJ, Rabin HR, Regelmann WE, Schidlow DV, Stokes DC, Wohl ME, Kaplowitz H, Wyatt MM, StrykerS. Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada. Pediatr Pulmonol 1999;28:231-241.
69. Aurora P, Bush A, Gustafsson P, Oliver C, Wallis C, Price J, Stroobant J, Carr S, Stocks J. Multiple-breath washoul as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med 2005;171:249-256.
70. Aurora P, Wade A. Wasting as predictor of survival in CF. Thorax 2002;57:468.
71. Aurora P, Wade A, Whitmore P, Whitehead B. A model for predicting life expectancy of children with cystic fibrosis. Eur Respir J 2000;16:1056-1060.
72. Gulmans VA, van Veldhoven NH, de Meer K, Helders PJ. The six-minute walking test in children with cystic fibrosis: reliability and validity. Pediatr Pulmonol 1996;22:35-89.